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Abstract
Participation in research can provide direct and indirect benefit to individuals with autism spectrum disorder (ASD), their
caregivers, families, and society at large. Unfortunately, individuals with high support needs, including those with intellectual disability, cognitive disability or minimal verbal ability, are often systematically excluded from research on ASD. This
limits the ability to generalize discoveries to all people with ASD, and results in a disparity in who benefits from research.
This piece outlines the importance and extent of the problem, which is part of a broader lack of inclusivity in ASD research.
It also provides examples of studies that have directly addressed issues that arise when conducting inclusive research and
makes recommendations for researchers to reduce disparities in research participation.
Keywords Intellectual Disability · Research · Participation · Inclusion

Introduction
A significant source of heterogeneity in autism spectrum
disorder (ASD) relates to accompanying intellectual impairment, which commonly rises to the level of intellectual disability (ID). The Centers for Disease Control estimates that
31–50% of those with an ASD diagnosis also meet criteria
for ID (Christensen et al., 2019; Maenner et al., 2020), and
a significant minority may be considered “minimally verbal”
(Tager-Flusberg et al., 2017). People with ID (with or without ASD) are almost entirely excluded from general medical research (Spong & Bianchi, 2018), but this exclusion
persists even in research on ASD, a population in which
people with ID are a plurality. One meta-analysis estimated
that only 6% of participants in ASD research have ID (Russell et al., 2019). While these reports have raised awareness, it still appears that this trend may be worsening over
time; one meta-analysis of ASD treatment studies indicated
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that the rate of inclusion of severely affected children with
ASD has decreased between 1991 and 2013 (Stedman et al.,
2018). However, because the cognitive and verbal ability
of research participants often goes unreported, these estimates—however dramatic—may still not reflect the full
extent of the exclusion (Stedman et al., 2018). In this article
we describe the extent and the causes of the exclusion of
people with ID + ASD from research on ASD, its implications, and paths to resolving it.

Reasons for the Exclusion of People with ID
from ASD Research
The exclusion of people with ID from ASD research may
be through formal means – inclusion and exclusion criteria
– or the incidental result of certain methodological features
of the study, as described below. Often, the exclusion of
people with ID + ASD is tacit; common exclusion criteria
may be proxies or strong risk factors for ID, such as an identified genetic condition, a significant neurologic condition,
or premature birth.
We performed a non-systematic review of actively
recruiting studies registered with ClinicalTrials.gov (dates
of access: August 11, 2020 and March 08, 2021; full details
of the search and results are available upon request) which
listed as the condition or disease “autism” (n = 224) or
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“intellectual disability” (n = 162). ASD studies were deemed
exclusive of ID if exclusion criteria included cognitive
impairment, comorbid developmental or learning disability, IQ in the ID range, or genetic diagnosis of a disease
strongly associated with ID (e.g., fragile X syndrome). Studies which excluded any portion of the ID population, even
if they allowed participants with mild ID (e.g., IQ > 50),
were categorized as exclusionary. ID studies were deemed
exclusive of ASD if their exclusion criteria included an ASD
or developmental disability diagnosis. We found that 42%
(n = 95) of ASD studies registered with ClinicalTrials.gov
explicitly or implicitly exclude people with ID from participation. However, almost no current ID studies restrict
participation for individuals with ASD (n = 6, 4%). This begs
the question: Why do ASD research samples not include
people with ID + ASD?
Many studies stratify or ensure representativeness on the
basis of age and sex, and the complexity of achieving this
balance across intellectual ability or other neurodevelopmental features would require larger sample sizes than are feasible in a field that already contends with sample size limitations. Methodological aspects of a study may prevent people
with ID + ASD from participating; people with ID + ASD
may have limited ability to read, write, communicate, process directions, and attend for long periods of time, which
may make certain procedures less feasible (Jack & Pelphrey,
2017). The neuropsychological tools that researchers use to
assess research participants often have limited validity for
use in ID + ASD (Havdahl et al., 2016). Even tools designed
to measure IQ, a core feature of ID, contain floor effects and
often lack standardization beyond four standard deviations
from the population mean. In fact, people with severe-toprofound ID are not represented at all in the standardization
samples of many commonly used research measures (Soorya
et al., 2018). Thus, in an effort to maintain the internal validity of a study, researchers may restrict participation to those
who can successfully complete a task or measure. This
choice differentially affects people with ID and adversely
affects the generalizability of the results.
Self-exclusion may also be a factor, and studies are beginning to document reasons why individuals and their families may choose not to participate in research (Cleaver et al.,
2010; Haas et al., 2016). One reason is the societal stigma
associated with ID, which may prevent participation in many
community activities (Werner & Roth, 2014) and lead to a
justified fear of unequal treatment. Even if they are interested
in research participation, individuals with ID + ASD or their
families may have concerns about the amount of time it takes
to prepare for or complete the study, alternative approaches
or coaching required to facilitate research participation,
and general burden in relation to the potential for benefit
(Haas et al., 2016). Individuals with ID + ASD and their
caregivers/families may experience frustration as a result of
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psychometric limitations, as the assessments may not seem
appropriate for the participant (Kelleher et al., 2020). As a
result, caregivers and people with ID + ASD who elect to
participate in research may experience isolation, which is
likely to prohibit future participation.
The potential for ethical issues—real or presumed—
can also limit participation by people with ID + ASD or
limited verbal ability, especially adults (Biros, 2018). The
additional effort required to adapt existing consent materials
may be onerous to investigators, and capacity assessments
may be necessary for adults if guardianship is not established. Parents or siblings may have legal guardianship, and
while consenting of guardians is legal in most places under
most circumstances, there are limitations (Horner-Johnson
& Bailey, 2013). Some researchers and review boards have
expressed concern about the ethics of enrolling adults with
ASD who cannot consent, which may not necessarily reflect
the views of the potential participants themselves (McDonald et al., 2018). As discussed below, the extreme stance
that safeguards to such vulnerable populations should prohibit research participation altogether carries its own ethical
burden. Researchers are therefore working to standardize
methods for and educate those in best practice of consenting
individuals who may not have capacity to consent (Biros,
2018).
Ethical and Scientific Implications of the Exclusion of
People with ID + ASD from ASD Research.
It is useful to explicitly establish why the exclusion of
people with ID from ASD research is unacceptable. There
is a relevant ethical imperative conferred by the fact that
people with ID are a vulnerable population, especially given
the historical maleficence towards them (Iacono & CarlingJenkins, 2012). However, when people with ID are excluded
from research, they do not benefit from research; “seeking to protect people from harm in the context of research
may itself therefore give rise to harm” (Northway, 2014).
The assumption that scientific knowledge generated in the
absence of individuals with ID + ASD may be simply generalized to all people with ASD runs counter to the basic tenets
of the scientific method. Moreover, excluding people with
ID + ASD from ASD research adversely affects the validity
of the results in ways that may be difficult to predict. Recent
studies highlight the impact of this selection bias on treatment research (Stedman et al., 2018), neuroimaging research
(Jack & Pelphrey, 2017), and on ASD research in general
(Russell et al., 2019).
The lack of representation of ID in research exploring the
neurobiology and etiology of ASD is particularly problematic, because both within ASD and in the general population,
people with ID are more likely than others to have an identifiable genetic condition (Myers et al., 2020). Recent research
also implicates unique neurobiological mechanisms for
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individuals with minimal verbal ability, even compared to
those without low cognitive or verbal performance, including differences in functional connectivity (Gabrielsen et al.,
2018) and auditory processing (Roberts et al., 2019).
Because ID + ASD is associated with greater ASD symptom severity and a greater likelihood of behavior problems
(Maskey et al., 2013; Soorya et al., 2018), criteria which
exclude people with ID + ASD may truncate the phenotypic range represented within a study. As a result, existing
research has limited applicability to people who may need
the most support. An understanding of the true prevalence
of comorbidities and the impact of the unique behavioral
phenotype on treatment efficacy is limited (Stedman et al.,
2018), which complicates efforts to ensure personalized
and individualized approaches to treatments. If clinical trials do not include people with ID + ASD, regulatory bodies
may exclude them from clinical indications for approved
treatments (Yazdani et al., 2020); this may in turn result
in the exclusion of people with ID + ASD from guidelines
published by governmental agencies or reimbursement payers. The seriousness of these potential outcomes prompted
the American Academy of Child and Adolescent Psychiatry to advocate for the inclusion of people with ID + ASD
in both natural history and treatment studies of psychiatric
comorbidity (American Academy of Child & Adolescent
Psychiatry, 2013).

Strategies to Improve Inclusivity
In recent years, increased attention to the lack of generalizability of ASD research has led to several attempts to ensure
that people with ID + ASD are studied. Such approaches fall
into two areas: one reflects the need to improve inclusion of
people with ID + ASD in the existing ASD research portfolio, while the other involves modifying the research portfolio to fill research gaps for people with ID + ASD by overenriching or even exclusively recruiting individuals with
ID + ASD into studies. The latter approach is especially relevant for clinical phenomena that are specific to people with
ID + ASD, including the evaluation of treatments already
studied in individuals without ID.
Some researchers have modified modalities in which it is
traditionally difficult for people with ID to participate, such
as neuroimaging. Alternative procedures, such as scanning
during sleep or sedation, have been used (Jack & Pelphrey,
2017), and behavioral techniques to optimize EEG cap placement and stillness in the MRI have been developed (Nordahl
et al., 2016; Tager-Flusberg et al., 2017). These approaches
include using a trained behavioral specialist, mock scanner
sessions, and additional scans to ensure acceptable resolution. While some success has been documented (Nordahl
et al., 2016), the additional staff, equipment, and time

required by this approach may require increased budgets,
staff members, and continued development to increase success. All of these elements, including developing manuals
for such adaptations, should be built into projects.
Researchers can use the principles of inclusive or participatory action research (Werner & Roth, 2014) to develop
study protocols that enroll individuals with ID + ASD. This
could even include training people with ID to be part of the
research process (e.g., Tuffrey‐Wijne et al., 2020). While
this may require additional and alternative methods for certain types of data acquisition (e.g., visual instructions) (Boxall & Ralph, 2011), the systematic piecewise introduction of
new methods will be essential to help clarify how findings
are affected by methodological differences. Likewise, new
methods may require even further modification to include
those in the severe and profound range of ID (see Maes et al.,
2021 for a description of such recommendations).
Researchers should explicitly justify inclusion/exclusion criteria that may affect the ability of individuals with
ID + ASD to participate in ASD research; this practice may
highlight areas where the wholesale exclusion of people with
any level of ID is not necessary. The inclusion/exclusion criteria should be tailored to the specific demands of the study,
to avoid excluding more people than necessary. For example,
rather than excluding generally based on ID, a study may
include participants who can achieve a score above the floor
of a given IQ test, but who also have a mental age of at least
18 months to comply with the demands of autism diagnostic
testing. Finally, researchers should carefully discuss how the
explicit or implicit exclusion of people with ID + ASD may
impact the validity and generalization of their findings.
Studies which recruit based on genetic etiology, or otherwise do not specify any particular neurodevelopmental
presentation and may therefore reflect a wide range of phenotypic expression, should use a tiered approach to tests and
procedures to accommodate all levels of cognitive ability
(Soorya et al., 2018). For instance, a developmental or IQ
test may be selected from a hierarchy based on the ability level of the participant, following systematic guidelines
described in a study protocol. While different tests are not
fully exchangeable, a consistent test hierarchy employed
across studies would allow for broad estimation of cognitive level. Where possible, measures that span a wide age
and developmental range should be employed, to allow for
successful measurement across the entire sample.

The Future of Inclusive Research on ASD
Given the strides made in research on understanding and
treating ASD over the past 75 + years, we are well-poised
to address the persistent exclusion of people with ID + ASD
from future work as we aim to learn more about how the
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condition affects all of those who are diagnosed with it. We
must focus on ways to be more inclusive in studies that aim to
be generalizable to all people with ASD, which must include
people with ID. However, we must also remember that people
with ID + ASD may require focused study, particularly around
etiology and treatment. To achieve these goals, a comprehensive approach is required, including a) increased flexibility for
study engagement to reduce participant and family burden,
b) increased workforce training, including clinical training
around ID for professionals (e.g., pediatricians, psychologists
and psychiatrists), research staff, community liaisons, and others who may work directly on improving research methods
for this population, c) new methods to increase the participation, compliance, and success of individuals with ID in clinical research (e.g., mobile technology, telehealth, telemetric
assessments, use of alternative and augmentative communication), including both standardized and non-standardized measures, and most importantly, d) an overall goal of research that
is relevant and useful for people with ID + ASD. This is to
ensure there is better inclusion of, and more rigorous reporting of, cognitive abilities in study participants.
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